Skip to main content
CRSP
NASDAQ Life Sciences

CASGEVY Revenue Surges 151% YoY to $76M; FDA Expands Approval to Children as Young as 2

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$50.7
Mkt Cap
$4.781B
52W Low
$44.12
52W High
$78.48
52W Position info
15% above low
Off High info
35% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

CRSP is trading near its 52-week low of $44.12 (15% above the low).

Summary

CRISPR Therapeutics delivered a strong Q2 with CASGEVY revenue hitting $76 million, up 151% year-over-year and 78% sequentially, signaling rapid commercial uptake. The FDA's approval for children aged 2 and older opens a new patient segment of roughly 5,500, significantly expanding the addressable market. The company also advanced its pipeline with Phase 1 initiations for CTX340 in refractory hypertension and CTX460 in AATD, and a late-breaking abstract on CTX310 durability will be presented at ESC Congress on August 28. This follows the May 2026 news of six assets nearing pivotal data, reinforcing a broad catalyst-rich second half. With a cash runway extended to at least 24 months from the recent $600 million convertible note issuance, the financial position supports these advancing programs.

At the time of this announcement, CRSP was trading at $50.70 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.8B. The 52-week trading range was $44.12 to $78.48. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

CRSP - Latest Insights

CRSP
Nov 10, 2026, 1:48 PM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $45.48
Real-time Price: $40.42 info
Change: -$5.06 (-11%) info
Market Cap: $3.924B info
CRSP
Nov 09, 2026, 9:16 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $50.42
Real-time Price: $40.42 info
Change: -$10.00 (-20%) info
Market Cap: $3.924B info
CRSP
Nov 02, 2026, 4:10 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $49.98
Real-time Price: $40.42 info
Change: -$9.56 (-19%) info
Market Cap: $3.924B info
CRSP
Nov 02, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $49.01
Real-time Price: $40.42 info
Change: -$8.59 (-18%) info
Market Cap: $3.924B info
CRSP
Nov 02, 2026, 4:06 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $49.01
Real-time Price: $40.42 info
Change: -$8.59 (-18%) info
Market Cap: $3.924B info